FrancisKEshunMD

Pediatric Hematology & Oncology • Phoenix, AZ

Attending at Phoenix Children's Hospital

Join to view full profile

Dr. Eshun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eshun's full profile

Already have an account?

Office
1919 E Thomas Rd
Bldg C
Phoenix, AZ 85016
Phone+1 602-546-4689

Fax+1 602-546-4683

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Lincoln Medical and Mental Health CenterResidency, Pediatrics, 2002 - 2005
University of Ghana Medical SchoolClass of 1996

Certifications & Licensure

AZ State Medical License 2008 - 2024
OH State Medical License 2005 - 2009
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Mar 04
Completed
Not Applicable
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

63 citations
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen A. Neville
Scientific Reports. 2018-09-27
29 citations
VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells
Mark A. Currier, Francis Eshun, Allyson Sholl, Artur Chernoguz, Kelly M. Crawford
Molecular Therapy. 2013-05-01
46 citations
Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients.
Pooja Hingorani, Mary Maas, Michael P. Gustafson, Paul S. Dickman, Roberta H. Adams
Journal for Immunotherapy of Cancer. 2015-08-18